Lumican is a potential predictor on the efficacy of concurrent chemoradiotherapy in cervical squamous cell carcinoma

PURPOSE: To identify new novel biomarkers for predicting the efficacy of concurrent chemoradiotherapy(CCRT) in cervical squamous cell carcinoma(CESC). METHODS: Gene expression datasets GSE56363, GSE5787, and GSE168009 were analyzed to identify candidate genes to predict the efficacy of CCRT in CESC....

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Ge, Xiao, Ying, Ma, Chanchan, Wang, Jinyun, Qian, Xiaotao, Wu, Xiaowei, Zhu, Fengqin, Sun, Shiying, Qian, Junchao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362307/
https://www.ncbi.nlm.nih.gov/pubmed/37483824
http://dx.doi.org/10.1016/j.heliyon.2023.e18011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362307/
https://www.ncbi.nlm.nih.gov/pubmed/37483824
http://dx.doi.org/10.1016/j.heliyon.2023.e18011

Ejemplares similares